Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. (Q43681780)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2001

Language	Label	Description	Also known as
English	Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.	scientific article published in July 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gómez-Lus R

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Adrián F

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

del Campo R

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Gómez-Lus P

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sánchez S

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

García C

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Rubio MC

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

49-54

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Antimicrobial chemotherapy for legionnaires' disease: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rote of the quinolones in the treatment of legionellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of Legionella species to antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of arbitrarily primed polymerase chain reaction, ribotyping, and monoclonal antibody analysis for subtyping Legionella pneumophila serogroup 1

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of charcoal on MICs for Legionella

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of azithromycin against clinical isolates of Legionella species

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900339-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(01)00339-9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43681780&oldid=2102477890"